ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,087Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 324

$541K Total Retail Price of All Prescriptions

Rank: 87 out of 324

562 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 562 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 562 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 9,187 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 569 504 1 1
LEVOTHYROXINE SODIUM 421 385 2 2
AMLODIPINE BESYLATE 380 349 3 4
HYDROCODONE-ACETAMINOPHEN 361 248 S3 4 5
OMEPRAZOLE 294 217 5 6
METFORMIN HCL 274 216 6 9
GABAPENTIN 252 207 7 13
FUROSEMIDE 232 206 8 7
LISINOPRIL 230 194 9 3
TRAMADOL HCL 229 189 10 19
ATORVASTATIN CALCIUM 205 177 11 12
LOSARTAN POTASSIUM 186 140 12 15
POTASSIUM CHLORIDE 178 148 13 8
WARFARIN SODIUM 169 157 14 10
ALENDRONATE SODIUM 147 142 15 24
ZOLPIDEM TARTRATE 136 82 16 20
ALLOPURINOL 125 112 17 27
HYDROCHLOROTHIAZIDE 119 115 18 11
METOPROLOL TARTRATE 118 114 19 14
METOPROLOL SUCCINATE 116 84 20 17
MELOXICAM 115 99 21 29
TAMSULOSIN HCL 111 101 22 26
SYNTHROID 110 106 23 30
DONEPEZIL HCL 110 110 23 25
PRAVASTATIN SODIUM 101 71 25 21
FINASTERIDE 99 89 26 101
ATENOLOL 99 89 26 18
NEXIUM 94 80 28 33
ESTRADIOL 91 91 R 29 98
CITALOPRAM HBR 86 68 30 16
GLIMEPIRIDE 83 61 31 37
PANTOPRAZOLE SODIUM 82 67 32 34
FLUTICASONE PROPIONATE 79 69 33 32
CLOPIDOGREL 79 67 33 38
CYCLOBENZAPRINE HCL 79 34 R 33 51
PREMARIN 78 77 R 36 122
FENOFIBRATE 76 70 37 79
CARVEDILOL 72 67 38 22
CIPROFLOXACIN HCL 68 53 39 55
AZITHROMYCIN 67 55 40 48
PLAVIX 67 55 40 63
TRIAMTERENE-HCTZ 67 67 40 46
SERTRALINE HCL 63 51 43 23
PAROXETINE HCL 62 54 44 72
ZETIA 59 59 45 68
LOSARTAN-HYDROCHLOROTHIAZIDE 59 57 45 44
BYSTOLIC 52 50 47 111
DIGOXIN 51 38 48 40
LANTUS 51 47 48 39
AMLODIPINE BESYLATE-BENAZEPRIL 50 36 50 100
FLUOXETINE HCL 50 36 50 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.